Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States

被引:124
作者
Khan, K
Muennig, P
Behta, M
Zivin, JG
机构
[1] New York Presbyterian Hosp, Dept Publ Hlth, New York, NY USA
[2] New York Presbyterian Hosp, Dept Med, Div Int Med & Infect Dis, New York, NY USA
[3] New York Presbyterian Hosp, Dept Pharm, New York, NY USA
[4] Cornell Univ, Weill Med Coll, New York, NY USA
[5] Columbia Univ, Program Gen Publ Hlth, New York, NY USA
[6] Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA
[7] Columbia Univ, Int Ctr Hlth Outcomes & Innovat Res, New York, NY USA
[8] CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10021 USA
关键词
D O I
10.1056/NEJMsa021099
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In the United States, an increasingly disproportionate burden of tuberculosis among the foreign-born population has led to calls for improvements in the detection and treatment of latent infection in new immigrants. Current treatment guidelines do not take into account global differences in drug-resistance patterns or their implications for the treatment of immigrants. The use of multinational surveillance systems to guide the management of latent infection according to region-specific drug-resistance profiles could improve the efficiency of efforts to reduce the burden of tuberculosis in immigrants to the United States. Methods: We constructed a decision-analysis model by using a hypothetical cohort of all documented immigrants entering the United States from developing nations. Region-specific drug-resistance profiles were derived from data on 30,388 cases of infection. The model examined the effectiveness and cost effectiveness of four strategies: no intervention or tuberculin skin testing followed by treatment with isoniazid, treatment with rifampin, or treatment with rifampin plus pyrazinamide for those with a positive test result. Results: A strategy of detecting and treating latent tuberculosis infection was cost-saving among immigrants from Mexico, Haiti, sub-Saharan Africa, South Asia, and developing nations in East Asia and the Pacific. This strategy was highly cost effective among immigrants from other developing nations. Rifampin plus pyrazinamide was the preferred strategy for treating latent infection in immigrants from Vietnam, Haiti, and the Philippines. Conclusions: For new immigrants to the United States from developing nations, a strategy of detecting and treating latent tuberculosis infection would lead to substantial health and economic benefits. Because of the high prevalence of resistance to isoniazid, treatment with a rifampin-containing regimen should be strongly considered for immigrants from Vietnam, Haiti, and the Philippines.
引用
收藏
页码:1850 / 1859
页数:10
相关论文
共 55 条
[1]  
*AG HEALTHC RES QU, 2002, HEALTC COST UT PROJ
[2]  
*AM PUBL TRANSP AS, 2002, PASS FAR SUMM
[3]  
[Anonymous], 2000, Ending neglect: the elimination of tuberculosis in the United States
[4]  
[Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733
[5]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[6]   HEALTH-CARE EXPENDITURES FOR TUBERCULOSIS IN THE UNITED-STATES [J].
BROWN, RE ;
MILLER, B ;
TAYLOR, WR ;
PALMER, C ;
BOSCO, L ;
NICOLA, RM ;
ZELINGER, J ;
SIMPSON, K .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (15) :1595-1600
[7]  
*BUR LAB STAT DEP, 2002, CONS PRIC IND
[8]  
*BUR LAB STAT DEP, 2002, NAT EMPL WAG DAT OCC
[9]  
*CDCP, 1996, NAT TUB SURV SYST
[10]  
*CDCP, 2002, TUB CAS FOR BORN PER